To evaluate the alterations on surgical outcomes after of the implementation of 3D laparoscopic technology for the surgical treatment of early-stage cervical carcinoma.
Data of patients undergoing type B radical hysterectomy (with or without bilateral salpingo-oophorectomy) and pelvic lymphadenectomy via 3D laparoscopy were compared with a historical cohort of patients undergoing type B radical hysterectomy via conventional laparoscopy. Complications (within 60 days) were graded per the Accordion severity system.
Data of 75 patients were studied: 15 (20%) and 60 (80%) patients undergoing surgery via 3D laparoscopy and conventional laparoscopy, respectively. Baseline patient characteristics as well as pathologic findings were similar between groups (p>0.1). Patients undergoing 3D laparoscopy experienced a trend toward shorter operative time than patients undergoing conventional laparoscopy (176.7 ± 74.6 vs 215.9 ± 61.6 minutes; p = 0.09). Similarly, patients undergoing 3D laparoscopic radical hysterectomy experienced shorter length of hospital stay (2 days, range 2-6, vs 4 days, range 3-11; p<0.001) in comparison to patients in the control group, while no difference in estimated blood loss was observed (p = 0.88). No between-group difference in complication rate was observed.
3D technology is a safe and effective way to perform type B radical hysterectomy and pelvic node dissection in early-stage cervical cancer. Further large prospective studies are warranted in order to assess the cost-effectiveness of the introduction of 3D technology in comparison to robotic assisted surgery.
Tumori 2017; 103(1): 76 - 80
Article Type: ORIGINAL RESEARCH ARTICLE
AuthorsFrancesco Raspagliesi, Giorgio Bogani, Fabio Martinelli, Mauro Signorelli, Cono Scaffa, Ilaria Sabatucci, Domenica Lorusso, Antonino Ditto
- • Accepted on 06/09/2016
- • Available online on 03/10/2016
- • Published in print on 21/01/2017
This article is available as full text PDF.
- Raspagliesi, Francesco [PubMed] [Google Scholar]
- Bogani, Giorgio [PubMed] [Google Scholar] , * Corresponding Author (email@example.com)
- Martinelli, Fabio [PubMed] [Google Scholar]
- Signorelli, Mauro [PubMed] [Google Scholar]
- Scaffa, Cono [PubMed] [Google Scholar]
- Sabatucci, Ilaria [PubMed] [Google Scholar]
- Lorusso, Domenica [PubMed] [Google Scholar]
- Ditto, Antonino [PubMed] [Google Scholar]
Gynecologic Oncology Unit, National Cancer Institute, Milan - Italy